✦ LIBER ✦
A randomized multicenter open label phase II study to determine the safety and efficacy of induction therapy with imatinib (Glivec, formerly STI571) in comparison with standard induction chemotherapy in elderly (>55
✍ Scribed by B. Wassmann; N. Gökbuget; U.J. Scheuring; A. Binckebanck; R. Reutzel; H. Gschaidmeier; D. Hoelzer; O.G. Ottmann; GMALLStudy Group
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 176 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.